Why predictive retina models could be the future of IND applications
In this interview, discover how retina models are revolutionizing rare disease treatment and accelerating drug development. What are the biggest ...
Tag: Organoids
$1 million grant supports research on groundbreaking therapies for MS
Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide. In MS, the ...
Researchers develop strategies to identify regulators of intestinal hormone secretion
A multi-institutional group of researchers led by the Hubrecht Institute and Roche's Institute of Human Biology has developed strategies to ...
Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies
By developing lab-grown intestines, researchers identified two unique molecular subtypes of Crohn’s disease, providing critical insights for personalized therapeutic approaches ...
Study reveals how SARS-CoV-2 triggers diabetes by destroying pancreatic cells
Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus ...
Scientists explore early life factors contributing to SMA
Spinal muscular atrophy (SMA) is a severe neurological disease for which there is presently no cure, although current therapies can ...
Human mini-lungs mimic animal response to nanomaterials
Human mini-lungs grown by University of Manchester scientists can mimic the response of animals when exposed to certain nanomaterials. The ...
Microfluidic chips advance neurodegenerative disease research
A review article published in the journal Nature Communications provides a detailed overview of recent developments in microfluidic chip models ...
Tecan offers end-to-end solutions for cellomics: automated workflows from single-cell dispensing to 3D spheroid analysis
Tecan is proud to offer end-to-end cellomics workflow solutions, including cell seeding and culture with quality control and monitoring, through drug ...
mRNA therapy revives p53 to combat ovarian tumors
Ovarian cancer is often very aggressive and responds poorly to the therapies currently available. A recent study by Goethe University ...
